Nephrotic syndrome as a clinical manifestation of systemic sclerosis

Rheumatology International

Volumn 27, Issue 11, 2007, Pages 1087-1089

  Wielosz, Ewa ^a   Majdan, Maria ^a   Suszek, Dorota ^a   Smarz Widelska, Iwona ^b   Korolczuk, Agnieszka ^a   Korobowicz, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b District Specialist Hospital   (Poland)

Author keywords

Membranous glomerulonephritis; Nephrotic syndrome; Renal involvement; Systemic sclerosis

Indexed keywords

ACETIC ACID DERIVATIVE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PEFLOXACIN; PREDNISONE; PROTEIN; SALICYLACETIC ACID; SCL 70 ANTIBODY; SIMVASTATIN; TICLOPIDINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; BACK; CASE REPORT; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; ECHOGRAPHY; EDEMA; FEMALE; GLOMERULONEPHRITIS; HOSPITAL ADMISSION; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEINURIA; RAYNAUD PHENOMENON; SKINFOLD; SYSTEMIC SCLEROSIS; THORAX; THORAX RADIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINARY TRACT INFECTION;

FEMALE; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MIDDLE AGED; NEPHROTIC SYNDROME; SCLERODERMA, SYSTEMIC;

EID: 34547830267     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0340-7     Document Type: Article

References (10)

1. Majdan M, Parada-Turska J, Suszek D (2004) Renal involvement in rheumatic diseases. Polskie Archiwum Medycyny Wewnȩtrznej 112:167-172
2. Balck C, Denton CP (1998) Scleroderma-systemic sclerosis. In: Davison AM, Cameron JS, Grunfeld JP (eds) Oxford textbook of clinical nephrology. Oxford University Press, New York, pp 961
3. Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH, Steen VD, Osial TA, Tolchin SF (1983) Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine 62:335-352
4. Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA (2005) Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 32:649-655
5. Simms RW, Korn JH (2001) Systemic sclerosis; the spectrum immunopathogenesis clinical features, and treatment. In: Adu D, Emery P, Madaio M (eds) Rheumatology and the kidney. Oxford University Press, New York, pp 275
6. Palma A, Sanchez-Palenica A, Armas JR, Milan JA, Fernandez-Sanz J, Llach F (1981) Progressive systemic sclerosis and nephrotic syndrome. Arch Intern Med 141:520-521
7. Kobayashi Y, Muraoka M, Tojo T (1977) Progressive systemie sclerosis sine scleroderma with nephrotic syndrome and suspected renal tubular acidosis. Nippon Naika Gakkai Zasshi 66:186-189
8. Bourne FM, Howell DA, Root HS (1960) Renal and cerebral scleroderma. Can Med Assoc J 82:881-886
9. Rihova Z, Honsova E, Merta M, Jancova E, Rysava R, Reiterova J, Zabka J, Tesar V (2005) Secondary membranous nephropathy-one center experience. Ren Fail 27:397-402
10. Jefferson JA Couser WG (2003) Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol 23:400-405